Michael Cookson to Genetic Therapy
This is a "connection" page, showing publications Michael Cookson has written about Genetic Therapy.
Connection Strength
0.166
-
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial. Lancet Oncol. 2021 01; 22(1):107-117.
Score: 0.166